miércoles, 7 de octubre de 2020

Retinoblastoma Treatment (PDQ®)–Health Professional Version - National Cancer Institute

Retinoblastoma Treatment (PDQ®)–Health Professional Version - National Cancer Institute

National Cancer Institute



Retinoblastoma Treatment (PDQ®)–Health Professional Version

General Information About Retinoblastoma

Retinoblastoma is a pediatric cancer that requires careful integration of multidisciplinary care. Treatment of retinoblastoma aims to save the patient's life and uses an individualized, risk-adapted approach to minimize systemic exposure to drugs, optimize ocular drug delivery, and preserve useful vision. For patients presenting with extraocular retinoblastoma, treatment with systemic chemotherapy and radiation therapy is likely to be curative. However, extraorbital disease requires intensive chemotherapy and may include consolidation with high-dose chemotherapy and autologous hematopoietic stem cell rescue with or without radiation therapy. While a large proportion of patients with systemic extra–central nervous system (CNS) metastases can be cured, the prognosis for patients with intracranial disease is dismal.

No hay comentarios:

Publicar un comentario